Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (398)	9/4/2001 12:30:16 PM
From: tuck	Read Replies (1) \| Respond to of 1005

Rick, Appreciate your take, as always. Hard to say if this is a big enough improvement for AngioMax to take share from Heparin or other stuff out there. The Street is saying "no" at the moment. Wonder how the pricing compares, and how big an issue that is. Anyhow, moving on to the last unlock day we're going to see for a long time: SGEN. Apparently, I never got around to putting up DD links as threatened. Better late than never . . . ipolockup.com Wilder's post concerning the heavily VC backed IPOs seems to be playing out according to script today. But so far, the volume isn't that big: siliconinvestor.com For a look at the trading history since the IPO: siliconinvestor.com There has been a little discussion of SGEN on its thread here: Subject 37481 SGEN raised $51 million in its IPO, $49 million + $2 million in a concurrent private placement to MEDX. Even most of these too young IPOs had the overallotment exercised, but not SGEN. Yahoo!'s current cash figures are borne out by the 10-Q: biz.yahoo.com Here's the S-1 -- no 10-K: 10kwizard.com And the most recent 10-Q: 10kwizard.com And the homepage: seattlegenetics.com SGEN's stock price is nowhere near cash levels. Have any biofreaks come to conclusions about the research premium? Even with today's price action, it's generously valued compared to some other BLUE H stocks followed here at about $100 million. Cheers, Tuck